|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Pulmonary and Critical Care Medicine, Georgetown University Medical Center, Washington, DC.
Correspondence to: Anne E. ODonnell, MD, FCCP, Division of Pulmonary and Critical Care Medicine, Georgetown University Medical Center, 3800 Reservoir Rd, NW, Washington, DC 20007-2197; e-mail: odonnela{at}georgetown.edu
Study objectives: To determine whether the spectrum of HIV-related pulmonary disease seen by a university medical center Pulmonary and Critical Care Medicine Service has changed since the introduction of highly active antiretroviral therapy (HAART).
Design: Retrospective chart review.
Setting: A tertiary care university hospital.
Patients: All HIV-infected patients referred to the Pulmonary and Critical Care Medicine Service from January 1, 1993, through December 31, 1995 (era 1) and from July 1, 1997, through June 30, 2000 (era 2).
Interventions: Inpatient and outpatient charts were reviewed for data regarding patient demographics, CD4 cell counts, viral load levels, duration of HIV seropositivity, history of opportunistic infections, and final diagnosis.
Results: Pneumocystis carinii pneumonia (PCP) was less common in the HAART era than in the pre-HAART era, whereas bacterial pneumonia and non-Hodgkins lymphoma (NHL) were more common in the HAART era than in the pre-HAART era. HAART was protective against PCP (odds ratio [OR], 0.37; confidence interval [CI], 0.16 to 0.89) in a manner dependent on the CD4 cell count. Patients receiving HAART were at increased risk for the development of bacterial pneumonia (OR, 2.41; CI, 1.12 to 5.17) and NHL (OR, 15.11; CI, 3.14 to 28.32). A history of PCP indicated a risk factor for bacterial pneumonia (OR, 2.14; CI, 1.13 to 4.04). A history of cytomegalovirus infection indicated a risk factor for NHL (OR, 6.0; CI, 1.27 to 28.32).
Conclusions: There have been significant changes in the spectrum of HIV-related pulmonary complications seen by our Pulmonary and Critical Care Medicine Service in the HAART era.
Key Words: bacterial pneumonia highly active antiretroviral therapy HIV non-Hodgkins lymphoma Pneumocystis carinii
This article has been cited by other articles:
![]() |
H. Khouli, A. Afrasiabi, M. Shibli, R. Hajal, C. R. Barrett, and P. Homel Outcome of Critically Ill Human Immunodeficiency Virus-Infected Patients in the Era of Highly Active Antiretroviral Therapy J Intensive Care Med, December 1, 2005; 20(6): 279 - 285. [Abstract] [PDF] |
||||
![]() |
C. R. Uphold, M. Deloria-Knoll, F. J. Palella Jr, J. P. Parada, J. S. Chmiel, L. Phan, and C. L. Bennett US Hospital Care for Patients With HIV Infection and Pneumonia: The Role of Public, Private, and Veterans Affairs Hospitals in the Early Highly Active Antiretroviral Therapy Era Chest, February 1, 2004; 125(2): 548 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
S H Allen, P Brennan-Benson, M Nelson, D Asboe, M Bower, B Azadian, B Gazzard, and J Stebbing Pneumonia due to antibiotic resistant Streptococcus pneumoniae and Pseudomonas aeruginosa in the HAART era Postgrad. Med. J., December 1, 2003; 79(938): 691 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Brecher, G. Aviram, and P. M. Boiselle CT and Radiography of Bacterial Respiratory Infections in AIDS Patients Am. J. Roentgenol., May 1, 2003; 180(5): 1203 - 1209. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |